Clozapine-induced Hypersalivation - Feasibility Trial

NCT02613494 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Sialorrhea

Interventions

DRUG: Hyoscine
DRUG: Glycopyrrolate
OTHER: Placebo

Sponsor

Mersey Care NHS Trust

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]